Developing Gene Therapies for Cardiomyopathies
Description
Learn about genetic variants in cardiomyopathies, along with gene therapy as a potential treatment with its possible benefits and risks.
Dr. Nicole Weaver, cardiac geneticist at Cincinnati Children’s Hospital, will moderate the Q&A portion.
The Speaker
Andrew Landstrom, MD, PhD, Associate Professor of Pediatrics at Duke University School of Medicine. He is a physician-scientist and cross-trained in pediatric cardiology, electrophysiology, human genetics and molecular physiology.